跳至主要内容
临床试验/EUCTR2016-000515-32-DK
EUCTR2016-000515-32-DK进行中(未招募)1 期

Antiplatelet and vascular effects of aspirin in healthy persons and patients with type 2 diabetes.

Per Løgstrup Poulsen0 个研究点开始时间: 2016年2月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Diabetics: Age > 18 years and a diagnosis of type 2 diabetes.
  • Controls: age > 18 years and exclusion of type 2 diabetes by oral glucose tolerance test.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 21
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 21

排除标准

  • Current treatment with antiplatelet drugs or anticoagulants including aspirin.
  • Treatment with non-steroidal antiinflammatory drugs.
  • Aspirin hypersensitivity.
  • Gastrointestinal bleeding within the last month.
  • Platelet disease and/or bleeding diseases.
  • Low platelet count (< 120 x 109/L).
  • Active cancer diagnose, chronic or acute infection, dialysis.
  • Known Cardiovascular disease.
  • Inability to give informed consent.

研究者

发起方
Per Løgstrup Poulsen

相似试验